Cultured AFB Antitubercular DST PAS Test
Comprehensive Tuberculosis Drug Sensitivity Testing
The Cultured AFB Antitubercular DST PAS Test represents a critical advancement in tuberculosis management and treatment optimization. This sophisticated diagnostic procedure specifically evaluates the sensitivity of Mycobacterium tuberculosis complex to para-aminosalicylic acid (PAS) and other essential antitubercular medications. As tuberculosis remains a significant global health concern, particularly with the rise of drug-resistant strains, this test provides physicians with vital information to develop targeted, effective treatment strategies.
What Does This Test Measure?
The Cultured AFB Antitubercular DST PAS Test employs automated fluorescent technology to assess the susceptibility of tuberculosis bacteria to various antitubercular drugs, with particular focus on:
- Para-aminosalicylic acid (PAS) sensitivity testing
- Multiple first-line and second-line antitubercular drugs
- Minimum inhibitory concentrations (MICs) for various medications
- Patterns of drug resistance development
- Bacterial growth inhibition in response to therapeutic agents
Who Should Consider This Test?
This specialized testing is recommended for individuals experiencing symptoms suggestive of tuberculosis or those requiring treatment monitoring:
- Patients with persistent cough lasting more than three weeks
- Individuals experiencing unexplained weight loss and fatigue
- Those with night sweats and low-grade fever
- Patients with known TB exposure or positive tuberculin skin tests
- Individuals with compromised immune systems
- Patients showing poor response to standard TB treatment
- Those with suspected drug-resistant tuberculosis strains
- Healthcare workers with potential TB exposure
Clinical Benefits of Drug Susceptibility Testing
Undergoing the Cultured AFB Antitubercular DST PAS Test provides numerous advantages for both patients and healthcare providers:
- Personalized Treatment Planning: Enables physicians to select the most effective antitubercular drugs based on individual bacterial sensitivity patterns
- Prevention of Treatment Failure: Identifies drug-resistant strains early to avoid ineffective therapy
- Reduced Side Effects: Helps eliminate unnecessary medications that may cause adverse reactions
- Cost-Effective Care: Prevents spending on ineffective treatments and reduces hospital stays
- Public Health Protection: Contributes to controlling the spread of drug-resistant tuberculosis
- Improved Treatment Outcomes: Increases the likelihood of complete recovery and reduces relapse rates
Understanding Your Test Results
Interpreting your Cultured AFB Antitubercular DST PAS Test results requires professional medical guidance, but here’s a general overview:
- Sensitive Results: Indicates the tuberculosis bacteria are susceptible to the tested drugs, suggesting standard treatment should be effective
- Resistant Results: Shows the bacteria are not affected by specific medications, requiring alternative treatment strategies
- Intermediate Sensitivity: May indicate partial resistance, requiring careful dosing considerations
- Multiple Drug Resistance: Identifies strains resistant to multiple first-line drugs, necessitating specialized treatment protocols
- Extensively Drug-Resistant (XDR): Indicates resistance to multiple first-line and second-line drugs, requiring highly specialized care
Your physician will review these results in the context of your overall health, symptoms, and medical history to develop the most appropriate treatment plan.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Cultured AFB Antitubercular DST PAS Test | $100 USD | $162 USD |
Nationwide Testing Availability
General Genetics Corporation provides comprehensive tuberculosis testing services across the United States. We have established testing facilities in all major metropolitan areas, including:
- New York City and surrounding regions
- Los Angeles and Southern California
- Chicago and the Midwest
- Houston and Texas metropolitan areas
- Phoenix and Arizona regions
- Philadelphia and the Northeast
- All other major cities throughout the USA
Our state-of-the-art laboratories utilize the latest automated fluorescent technology to ensure accurate, reliable results for tuberculosis drug susceptibility testing. With samples accepted daily until 3:30 PM and results typically available within 21 days, we provide timely diagnostic information to support effective tuberculosis management.
Take Control of Your Tuberculosis Treatment
Don’t let uncertainty about your tuberculosis treatment compromise your health. The Cultured AFB Antitubercular DST PAS Test provides the critical information needed to ensure you receive the most effective antitubercular therapy. Our experienced team is ready to assist you with convenient testing options and professional support throughout the process.
Book your test today by calling +1(267) 388-9828 or visit our website to schedule your appointment. Take the first step toward personalized, effective tuberculosis treatment with comprehensive drug sensitivity testing from General Genetics Corporation.
